1 | 20mg/0.5ml glatiramer acetate | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
2 | 40 mg glatiramer acetate | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 2件: 2 2, 13 |
3 | Cyclophosphamide/Glatiramer acetate | 3件: Acetate Acetate, Cyclophosphamide, Glatiramer (Synonym: Teva-glatiramer Acetate) | 2件: D00287
D00287
,
D07760
| - | - | 1件: 13 13 |
4 | Experimental Glatiramer Acetate | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
5 | GLATIRAMER ACETATE | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 3件: 13 13, 96, 156 |
6 | Glatiramer Acetate (Copaxone®) | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 2件: 13 13, 156 |
7 | Glatiramer Acetate (DB) | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
8 | Glatiramer Acetate (GA) | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
9 | Glatiramer Acetate (GA) 40 mg | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
10 | Glatiramer Acetate (GTR) | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
11 | Glatiramer Acetate (OL) | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
12 | Glatiramer acetate 150mg enteric coated tablets | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
13 | Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
14 | Glatiramer acetate 20 mg | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
15 | Glatiramer acetate 20 mg, with mitoxantrone | 3件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate), Mitoxantrone | 1件: D08224
D08224
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 13 13 |
16 | Glatiramer Acetate 20 mg/0.5 mL | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
17 | Glatiramer acetate 40 mg | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
18 | Glatiramer Acetate [GA] | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
19 | Glatiramer acetate injection with oral cetirizine hydrochloride | 3件: Acetate Acetate, Cetirizine, Glatiramer (Synonym: Teva-glatiramer Acetate) | 1件: D07662
D07662
| 1件: HRH1 HRH1 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
20 | Glatiramer acetate with minocycline | 3件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate), Minocycline | 1件: D05045
D05045
| - | - | 1件: 13 13 |
21 | Glatiramer acetate, (Copaxone®) | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
22 | Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b | 2件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate) | - | - | - | 1件: 13 13 |
23 | Glatiramer Acetate, N-Acetylcysteine | 3件: Acetate Acetate, Acetylcysteine, Glatiramer (Synonym: Teva-glatiramer Acetate) | 1件: D00221
D00221
| - | - | 1件: 13 13 |
24 | Human interferon beta-1a and glatiramer acetate | 4件: Acetate Acetate, Glatiramer (Synonym: Teva-glatiramer Acetate), Human interferon beta, Interferon beta-1a | 1件: D04554
D04554
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
25 | Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab | 12件: Acetate Acetate, Alemtuzumab, Cladribine, Dimethyl fumarate, Fingolimod, Glatiramer (Synonym: Teva-glatiramer Acetate), Natalizumab, Ocrelizumab, Ofatumumab, Ponesimod, Rituximab, Teriflunomide | 10件: D01370
D01370
,
D02802
,
D02994
,
D03846
,
D05218
,
D06886
,
D09314
,
D10001
,
D10172
,
D11215
| 7件: CD52 CD52, DHODH, ITGA4, KEAP1, MS4A1, RRM1, S1PR1 💬 | 31件: , Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬 | 1件: 13 13 |